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Abstract
Preterm delivery is defined as delivery before 37 weeks completed gestation. 
It represents a major cause of neonatal morbidity and mortality and accounts for 
5–10% of all deliveries. Cervical length assessment between 16–24 weeks and 
positive fetal fibronectin beyond 21 weeks gestation are proved to useful tools 
in prediction of preterm labour. Treating asymptomatic bacteruia and bacterial 
vaginosis in high-risk women reduces the incidence of preterm labour. Cervical 
cerclage is recommended to reduce the incidence of preterm birth in women with 
2nd trimester losses and those with cervical length of 25 mm or less on transvaginal 
ultrasound between 16–24 weks gestation. Atosiban and nifidipine are currently the 
agents of choice in tocolysis. Antenal steriods in womens with threating preterm 
labour reduces the perinatal morbidties. Magnisum sulphate role is established for 
neuroprotection especially in extreme gestations between 24–30 weeks. Vaginal 
delivery is mode of choice for delivery with consideration to avoid fetal blood sam-
pling, fetal scalp electrodes and ventouse prior to 34 weeks gestations. Caesarean 
section is considered for obstetric reasons that guide labour management at term.
Keywords: definition, maternal morbidity, feral morbidity, risk factors, tocolysis, 
antenatal steroids
Preterm delivery is defined as delivery before 37 weeks completed gestation. It 
represents a major cause of neonatal morbidity and mortality in both developed and 
developing countries with European and North American figures ranges between 
5–10% of all deliveries. In the UK it represents 7.3% of live births
Extreme preterm birth is defined as preterm birth prior to 28 weeks gestation. 
It accounts for 5–10% of preterm deliveries. The major concern of extreme preterm 
birth is the significant risk of neonatal mortality as the survival rates are very low 
at these gestations (0.4% at 22 weeks, 7% at 24 weeks) while the main concern of 
preterm births above 28 weeks is the neonatal morbidity as the survival rates are 
77% at 28 weeks and 97% at 36 weeks.
1. Aetiology
The aetiology of preterm labour is multifactorial with a common pathway 
resluting in increased relasee of prostaglandins and cytokines within the cervix, 
myometrium and fetal membranes. The release of prostaglandins is triggered 
by infective or inflammatory process [1], uterine overdistension as in cases with 




In modern obstetrics, 30–40% of preterm deliveries are iatrogenic. The most 
common cause of which is severe pre-eclampsia associated with intrauterine growth 
restriction (IUGR) and antenatal fetal distress. Other common iatrogenic preterm 
deliveries include, Grade 3 and 4 placenta praevia or placenta abruption with major 
bleeding, sever IUGR with absent or reversed end-diastolic flow. It is also notable 
that the increased number of large loop excision of transformation zone (LLETZ) 
procedures for abnormal cervical cells leads to cervical scarring and iatrogenic 
cervical incompetence and hence preterm delivery.
2. Prediction of preterm labour
Identifying high risk patients is crucial in managing and preventing preterm 
labour. Prediction of preterm labour is possble through; risk assessment, uterine 
activity monitoring, cervical length assessment and fetal fibronectin assessment.
2.1 History taking and risk assessment
Patients with previous preterm labour are at higher risk of having pretem term 
birth. The risk is 17% after one previous preterm delivery and increases to 28% 
after two preterm deliveries. Patients with previous preterm premature rupture of 
membranes (PROM) [2], previous second trimester loss and thoese who are known 
to have cervical incomptence and congenital uterine anaomalies are at higher risk 
for preterm birth. Fruther more uterine overdistention as with Polyhydraminos 
and mutiple pregnancy is associated with preterm delivery. Patient with placental 
abruption are also known to be at higher risk of preterm labour.
Scoring systems were developed in attempts to achieve accurate and numeri-
cal score to help the management of preterm labour. However; the scoring 
systems proved to have poor sensitivity and poor postive predictive values as 
more that 50% of preterm labour occurs in the first pregnancy and in womens 
with no risk factors [3].
2.2 Monitoring uterine activity
It notable that uterine activity increases prior to onset of pretrm labour by 
24 hours. However, the use of home uterine contraction monitors or self palpations 
has not proven to be useful as they had poor postive predictive vlaues and their use 
did not improve the perinatal outcomes.
2.3 Assessment of cervical length
Clinical assessment of cervical status in terms of dilatation, softening and 
effacement can predict preterm labour, However it has low sensitivity and repeated 
vaginal examination in it self may incease the cervical prostaglandins relase and 
subsquently increase the incidnce of preterm labour.
Utrasound assessment of cervical length is a reliable method and highest 
predictive value up to 70% is notable with cervical length under 25 mm in womens 
with risk factors for preterm labour. Serial cervical length assessment is recom-
mended in hight isk group between 16–24 weeks. Cervical length is best measured 
by transvaginal scan with empty bladder as full bladder may lead to false increase in 
the cervical length measurments. The risk of preterm labour increases from 1% at 
cervical length of 25 mm to 4% at 15 mm cervical length. The marked increased risk 




Cervical length assessment is not routine in womens with no risk factors for 
preterm birth as the positive predictive value is low in this group. Also, preventive 
interventions as cervical cerclage is not recommended in low risk group as they have 
shown no improvement in the outcome in this group [4].
The presence of funnelling of the internal os is another helpful finding in pre-
dicting the preterm birth, However, it is less accurate compared to cervical length 
assessment due to inter and intra observer variations [6].
2.4 Fetal fibronectin testing
Fetal fibronectin is normally present in high concentration prior to 21 weeks 
of gestation in cervical and vaginal secretions prior to membranes fusion. 
Inflammatory process, uterine overdistension and choriodecidual haemorrhage 
increase fetal fibronectin secretion after 21 weeks gestation.
Fetal fibronectin testing by swabbing the posterior fornix or ectocervix between 
22 and 34 weeks gestation in recommended as postive results in high risk group 
especially in presence of symptoms warrant admistration of steriods and hospital 
admission. Fetal fibronectin testing is not recommeded in womens with no risk fac-
tors as it has not shown to be effective in improving the outcome despite more than 
half of preterm birth occurs in this group [7].
Testing for fetal fibronectin is contraindicated before 22 weeks gestation, in 
presence of preterm premature rupture of membranes, active vaginal bleeding and 
intercourse in the previous 24 hours.
Other biochemical markers such as Insulin like growth factor binding protein-1, 
interleukin-6, interleukin-8 and tumour necrosis factor-alpha (TNF-α) were 
assessed in research setting for use in predicting preterm labour. However, none of 
those markers is currently used in routine practice [8].
3. Neonatal morbidity and mortality of preterm labour
Preterm birth is associated with significant neonatal morbidities such as respi-
ratory distress syndrome, necrotizing enterocolitis, retinopathy of prematurity, 
neonatal sepsis, intraventricular haemorrhage and periventricular leucomalacia. 
Longterm impact of prematurity are mainly cognitive and motor impairement 
which are more prevelant in extreme preterm births. Prolongation of pregnancy 
with tocolytic agents and adminstration of antenatal steriods signficantly reduces 
the neonatal morbidities in preterm births [1, 9].
EPICure data [9] may be useful tool in counselling the parents about fetal prog-
nosis. Neonatal mortality is higher with preterm birth at lower gestational ages with 
survival rate of 7% at 24 weeks compared to 77% at 28 weeks and 97% at 32 weeks. 
The survival rates improves 2.2% daily between 24 and 28 weeks gestions. Preterm 
delivery at 36 weeks is associated with 99% survival rate [1, 9, 10].
4. Prevention of preterm delivery
Mutiple preventive measures were tested for prevention of preterm labour such as 
treatment of asymptomatic bacteruria and bacterial vaginosis, prophylactic antibiotics 
in womens with postive fetal fibronectin and reduced cervical length, cervical cer-
clage, prophlactic tocolysis and hormonal supplements. Some were proved to be effec-
tive in reducing preterm deliveries while others shown no significant diffierence in the 
outcome regarding the incidance of preterm birth and its associated morbidities.
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a. Bacterial vaginosis occurs in 10–22% of pregnant womens with unknown 
aetiology. Treating the bacterial vagnoisis and hence reducing its associated 
inflammatory process was proved to reduce the incidance of preterm birth 
in womens with risk factors for preterm labour especially those with postive 
fetal fibronectin testing. Asymptomatic bacteruria occurs in 2–9% pregnant 
womens and its associated inflammtory process can participate in increasing 
prostagladins levels in cervicovaginal secretions and hence the preterm birth. 
Treating asymptomatic bacteruria in high risk group reduces the incidence of 
preterm birth but not in low risk group.
b. Antibiotic treatment for prophylactic antibiotics in womens with postive fetal 
fibronectin and in womens reduced cervical length in absence of infective or 
inflammatory process is not recommeded due to limited evidence and lack of 
proven efficacy.
c. Cervical cerclage proved to reduce the incidence of preterm birth in women 
with 2nd trimester losses and those with cervical length of 25 mm or less on 
transvaginal ultrasound between 16–24 weks gestation [4, 11]. Cervical cer-
clage can be done by transvaginal route (McDonald or Shirodkar techniques) 
or transadominal route when there is insufficient cervical tissue to hold the 
suture or when the vaginal approach has failed previously [1, 4]. Counselling 
prior such procedure is essential to involve the pros and cons. Complications 
of the procedure can include; bleeding, infection (endometritis), increased 
frequency of contractions, cervical trauma, preterm premature rupture of 
membranes, suture displacement, sepsis, cervical scarring. Cervical cerclage 
is contraindicated in presence of fetal anomaly, intrauterine infection, active 
bleeding and preterm premature rupture of membranes [1, 6].
d. Prophylactic tocolysis for high risk women has not proved to reduce the 
preterm birth rate and is not recommended.
e. Progesterone supplement via vaginal or intramuscular route on weekly basis 
till 36 weeks can be considered to promote reduction of uterine activity. Its 
use is limited to clinical trials in European guidlines [12, 13] while the recent 
NICE guideline in UK and in North America, progesterone supplementation is 
recommended for clinical use for reuction of preterm births [1, 14].
f. Use of cervical pessaries, bed rest and restrticting physical activity and inter-
course have no proved evidence of preventing preterm labour [15, 16].
5. Management of preterm labour
The mangement of preterm labour fall into five areas; the use of tocolysis, 
adminstration of antibiotics, admistration of antenatal steriods, magnisum sulphate 
for neuroprotection and finally the considerations for the mode of delivery.
6. Tocolysis
It is important to realise that the aim of tocolysis in modern obstertics is limited 
to gain few days to allow admistration of antenatal steriods which proved to reduce 
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Ritodrine and other b-agonists as terbutaline, salbutamol were used as tocolytic 
agent but currently not recommeded as first line due to its maternal and neonatal 
side effects. They act on b2 receptors in myometrial smooth muscles via a cAMP 
dependent mechanism leading to reduction in the intracellular calcium causing 
muscular relaxation. Cochrane review on B2-agonists concluded that they decrease 
the number of preterm births within 48 hours but not within 7 days [1, 17, 18].
Maternal side effects include; palpitations and arrhythmias, chest pain, 
hypotension, flushing, nausea, headache, pulmonary oedema, hypokalaemia and 
hyperglycaemia. Neonatal side effects include; tachycardia, hypotension, hypogly-
caemia, hypocalcemia and ileus. It is not proved that B2-agnosists are associated 
with neonatal periventericular haemorrhage [18].
8. Indomethacin
It is a nonsteroidal anti-inflamatory agent which inhibit cyclo-oxygenase enzyme 
and subsequently reduces myomeytrial prostaglandins concentration which inturn 
down regulates myometrial cells gap junctions, down regulates oxytocin receptors and 
reduces intracellular calcium levels. It has better tocolytic effect and better safety profile 
than b-agonists but its routine use is limited due to the associated fetal side effects [18].
Maternal side effects include; risks of peptic ulcerations, thrombocytopenia and 
postpartum haemorrhage and allergic reaction. Fetal side effects include; prema-
ture closure of ductus arteriosus. There is risk of neonatal necrotizing enterocolitis, 
intraventericular haemorrhage and renal dysfunction [18].
9. COX (cyclo-oxygenase)-2 inhibitors
It is a nonsteriodal anti-inflammatory agent which act specifically on cycloxge-
nase-2 enzyme which is upregulated in preterm labour. The mechanism of action 
is simillar to indomethacin but with better maternal side effect profile. Its routine 
use is limited due to fetal concerns over premature closure of the ductus and renal 
idysfunction [18].
10. Atosiban
Atosiban is an oxytocin analogue competitively blocks oxytocin and vasopressin 
receptors leading to reduced intracelluar calcium and lesser prostagladins produc-
tion. It is recommended and licenced in preterm labour [1, 18, 19]. Its side effects 
include; maternal nausea, vomiting, hot flushes, hypotension and dizzness. It has 
simillar effectivness to B2-agonists and nifidipine but with a safer profile however, 
it is more expensive and given intravenously [1, 18].
11. Nifedipine
It is a calcium channel blocker that is proved to be effective in reducing preterm 
birth with lesser side effects compared to B2-agonists. It is admnistered orally and 
it is considered first line treatment option [1, 18]. The side effects of its use include; 





Cochrane review did not support its use for tocolysis as studies repeorted did not 
show that magnesium sulphate delayed or prevented preterm birth [18].
13. Antibiotics
The use of antibiotics is recommeded with preterm premature rupture of 
membranes (PPROM) based on ORACLE trial and chochrane review which proved 
that they reduce the time to delivery and the incidence of chorioamnionitis. They 
also decrease the ioccurance of neonatal sepsis and the need for neonatal surfactant 
and oxygen therapy. On the other hand; the ORACLE trial did not recommed its use 
in preterm labour without premature rupture of membranes as there was no differ-
ence in the neonatal outcomes [1, 20, 21].
It is also concluded that erythromycin is a better choice compared to coamoxiclav 
in women with preterm labour associated with premature rupture of membranes due 
to increased risk of necrotizing enetrocoilitis with the use of co-amoxiclav [20, 21].
14. Antenatal steriods
The Royal College of Obstetricians and Gynaecologists (RCOG) recommeded 
the use of antenatal corticosteriods in women with threating preterm labour as it 
is proven that their use has significant reduction in neonatal respiratory distress 
syndrome, intraventricular haemorrhage and neonatal death without increase in 
neonatal sepsis in women who has preterm labour and PPROM.
The use of antenatal steriods is recommeded with threatening preterm labour 
between 24 weeks and 34 weeks gestations may be considered up to 35 + 6 weeks 
with the optimal benefit within a window of one to seven days [1, 22].
The agent of choice is betamethasone as it has lesser risk of periventericular 
leucomalacia compared to the use of dexamethasone [22].
It is recommeded that betamethasone is adminstered intramuscularly in patients 
with preterm labour as the oral adminstration is associated with higher risk of 
neonatal sepsis and intraventricular haemorrhage. It is recommended to be used as 
two doses of 12 mg, 24 hours apart.
The use of mutiple courses of antenatal steriods is not recommeded as per RCOG 
guidance as it is associated with increassed risks of maternal osteoprosis, infection 
and imparied glucose tolerance. Multiple courses of steriods is associated with fetal 
risks including; intrauterine growth restriction, low birth weight, necrotizing entero-
colitis, adrenal insufficiency and abnormal neurological development. Compared to 
a single course, mutiple courses have no benefit of improving neonatal respiratory 
distress syndrome, chronic lung disease and intraventericular haemorrhage [1, 22].
15. Magnisum sulphate for neuroprotection
Children born to women given magnesium sulphate for seizure prevention in 
severe pre-eclampsia were noted to have lower rates of cerebral palsy. This is pos-
sibly because magnisum decreases extracellular glutamate with hypoxia and hence 
reduces excitotoxicity. It also limits calcium influx through voltage-gated channels 
and in turn reduces the activation of apoptosis. Further more it reduces oxidative 
stress and reduces the production of pro-inflammatory cytokines.
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It is use for neuroprotection is recommeded for use in women with estab-
lished preterm labour or planned to hace elective preterm birth within 24 hours 
at  gestations between 24 and 30 weeks. It is can be considered between 30 and 
34 weeks [1, 23].
16. Mode of delivery
Vaginal delivery is considered to be appropriate choice in gestations under 
24 weeks as the neonatal survival rate is very low. The challanging decision is the 
balance of vaginal delivery versus caesarean section in preterm delivery between 
24 weeks and 37 weeks gestation [1, 24].
The decision for caesarean section is recommended to be for the obstetric rea-
sons such as malpresentations and intrapartum fetal distress. Cochrane review for 
elective caesarean section in women with threating preterm labour between 24 and 
37 weeks gestation has not shown statistically significant difference in the neonatal 
outcomes with regard the incidence of respiratory distress syndrome and neonatal 
seizures.
There is no evidence to support routine prophylactic outlet forceps or episiotomy 
when considering vaginal delivery between 24 and 37 weeks gestations. It is advis-
able to leave the fetal membranes intact till late in labour to reduce the risk of cord 
prolapse. The fetal scalp electrode and fetal blood sampling use is contraindicated 
prior to 34 weeks gestation and hence any suspicious fetal monitoring trace should 
be considered as indication for caesarean section. Their use is considered between 
34 and 36 weeks gestation. It is also important to note that ventouse delivery is 
contraindicated prior to 34 weeks gestation. Consideration should be taken for 
caesarean section in preterm delivery with breech presentation [1, 24].
Delayed cord clamping for at least 30 seconds but no longer than three minutes 
is advisable in preterm deliveries to allow auto transfusion of the baby. Senior 
obstetrician should be consulted in planning the delivery and the decision-making 
throughout the labour [1, 24].
Parents should have discussion with joint obstetric and neonatal team prior 
embarking onto labour is helpful to ensure their understanding of challenges for 
the preterm baby such as ability to maintain stable core body temperature, ability to 
breath spontaneously and feeding difficulties. The expected postnatal care for the 
preterm baby should be planned as detailed as possible with the parents and ensure 
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